This is a firm-fixed price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of Defense, to Qiagen, LLC. The contract, valued at $13,193.60, is for the provision of a QIACUBE HT system and associated services for a 12-month period, with a completion date of April 23, 2025. Qiagen is a global provider of sample and assay technologies for molecular diagnostics, applied testing, and academic research. The company has a history of supporting federal agencies through prime and subcontractor arrangements, delivering a range of products and services, including DNA/RNA extraction kits, sequencing technologies, and bioinformatics software. This contract does not have a set-aside designation.
Generated 7/22/24, 9:02 AM